TNF and Alzheimer disease: Additional inflammatory events in AD patients were associated with elevated baseline levels of TNFα (Holmes et al., 2009) and IL-1β (Holmes et al., 2003) and with an increased rate of cognitive decline over a 2 or 6-month period.